Novel Targets for the Development of Monoclonal Antibodies for Immunotherapy)

Last updated: February 19, 2025
Sponsor: Checkmab S.r.l.
Overall Status: Active - Recruiting

Phase

N/A

Condition

Healthy Volunteers

Treatment

N/A

Clinical Study ID

NCT06842407
ID3411
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The first objective of the project consists in the preclinical validation of new possible molecular targets associated with intratumoral T regulatory cells. The second objective consists in the selection of monoclonal antibodies with therapeutic potential, specific for the selected targets.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • blood donors

  • age of 18 years or more

  • able to sign informed consent

Exclusion

Exclusion Criteria:

  • age below 18 years

  • Positive for HIV, HCV, HBV

  • not suitable for blood donation

  • not able to understand or sign informed consent

Study Design

Total Participants: 600
Study Start date:
April 01, 2023
Estimated Completion Date:
June 30, 2026

Connect with a study center

  • S.C. Medicina Trasfusionale - Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

    Milan, 20122
    Italy

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.